Research Sample bioBank

Can’t find what you’re looking for? Contact us.

Or, need help ordering? 805.528.4341

Filter Samples By:

Get Weekly Research Sample Updates in your Inbox:

Hepatitis E Clinical Research Samples

Discovery Life Sciences provides the highest quality Hepatitis E Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank. 

  • All Hepatitis E Sample Orders are Packaged for Delivery within 24 Hours. 
  • All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
  • Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
  • Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations. 
Showing 69 of 69 total samples
 (0)
Checkout
Advanced Data View:
Showing 69 of 69 total samples
Buy
Product IDSampleOriginMatrixVial (ml)QuantityPriceAgeGenderEthnicityStorage TempSample DateTest 1Test Data 1Sample Detail 1Test 2Test Data 2Test 3Test Data 3Sample Detail 3Product
Details
Price
Buy
Additional Information 1Additional Data 1Additional Information 2Additional Data 2Additional Detail 2Additional Information 3Additional Data 3Additional Information 4Additional Data 4Additional Detail 4Additional Information 5Additional Data 5Additional Information 6Additional Data 6Additional Detail 6Additional Information 7Additional Data 7
DLS13-11678Hepatitis EFranceCPD2.0012.00$250.00 U/AU/A< -70C30-Oct-12Bio-Evolution PCR Tps ReelPositiveBio-Evolution ORF2 PCR Genotype 3Real-Time PCR2,940 cps/mLSequencing of the ORF2 region $250.00HCV, HIV, HTLV, HBc et AgHBs Neg DGV Neg Syphilis Nég.
DLS13-11679Hepatitis EFranceCPD2.0011.00$250.00 U/AU/A< -70C26-Sep-12Bio-Evolution PCR Tps ReelPositiveBio-Evolution ORF2 PCR Genotype 3fReal-Time PCR165,000 cps/mLSequencing of the ORF2 region $250.00HCV, HIV, HTLV, HBc et AgHBs Neg DGV Neg Syphilis Nég. Infection Réplicative à HEV
DLS13-11680Hepatitis EFranceCPD2.0015.00$250.00 U/AU/A< -70C17-Sep-12Bio-Evolution PCR Tps ReelPositiveBio-Evolution ORF2 PCR Genotype 3fReal-Time PCR2,440 cps/mLSequencing of the ORF2 region $250.00Sero HEV-IgGNegSero HEV-IgMNegHCV, HIV, HTLV, HBc et AgHBs Neg DGV Neg Syphilis Nég. Infection Réplicative à HEV
DLS13-11681Hepatitis EFranceCPD2.0013.00$250.00 U/AU/A< -70C05-Oct-12Bio-Evolution PCR Tps ReelPositiveReal-Time PCR132,000 cps/mLSequencing of the ORF2 region $250.00HCV, HIV, HTLV, HBc et AgHBs Neg DGV Neg Syphilis Nég.
DLS13-11682Hepatitis EFranceCPD2.002.00$250.00 < -70CBio-Evolution PCR Tps ReelPositiveBio-Evolution ORF2 PCR Genotype 3cReal-Time PCR502,000 cps/mLSequencing of the ORF2 region $250.00HCV, HIV, HTLV, HBc et AgHBs Neg DGV Neg Syphilis Nég.
DLS13-11683Hepatitis EFranceCPD2.0016.00$250.00 U/AU/A< -70C15-Oct-12Bio-Evolution PCR Tps ReelPositiveReal-Time PCR1,710 cps/mL$250.00HCV, HIV, HTLV, HBc et AgHBs Neg DGV Neg Syphilis Nég.
DLS13-11685Hepatitis EFranceCPD2.0017.00$250.00 U/AU/A< -70C12-Nov-12Bio-Evolution PCR Tps ReelPositiveReal-Time PCR10,900 cps/mLSequencing of the ORF2 region $250.00HCV, HIV, HTLV, HBc et AgHBs Neg DGV Neg Syphilis Nég.
DLS17-036561Hepatitis EFranceCPD1.003.00$250.0063 YMU/A<-70C22-Dec-15Altona HEV RT-PCR Kit534 copies/mLWANTAI HEV-IgM ElisaPositiveWANTAI HEV-IgG Elisa0.77 IU/mLPositive$250.00Genotype3fAdditional ResultsHCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative.
DLS17-036562Hepatitis EFranceCPD1.0021.00$250.0064 YMU/A<-70C04-Dec-16Altona HEV RT-PCR Kit23,100 copies/mLWANTAI HEV-IgM ElisaPositiveWANTAI HEV-IgG Elisa38.5 IU/mLPositive$250.00Genotype3cAdditional ResultsHCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative.
DLS17-036563Hepatitis EFranceCPD1.0015.00$250.0055 YMU/A<-70C07-Oct-15Altona HEV RT-PCR Kit1,070 copies/mLWANTAI HEV-IgM ElisaNegativeWANTAI HEV-IgG ElisaNegative$250.00Genotype3iAdditional ResultsHCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative.
DLS17-036566Hepatitis EFranceCPD1.001.00$250.0019 YMU/A<-70C22-Mar-16Altona HEV RT-PCR Kit1,140 copies/mLWANTAI HEV-IgM ElisaPositiveWANTAI HEV-IgG ElisaNegative$250.00Genotype3fAdditional ResultsHCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative.
DLS17-036567Hepatitis EFranceCPD1.006.00$250.0059 YMU/A<-70C03-May-16Altona HEV RT-PCR Kit15,600 copies/mLWANTAI HEV-IgM ElisaPositiveWANTAI HEV-IgG ElisaNegative$250.00Genotype3Additional ResultsHCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative.
DLS17-036568Hepatitis EFranceCPD1.004.00$250.0051 YMU/A<-70C11-Mar-15Altona HEV RT-PCR Kit8,930 copies/mLWANTAI HEV-IgM ElisaPositiveWANTAI HEV-IgG Elisa0.39 IU/mLPositive$250.00Genotype3fAdditional ResultsHCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative.
DLS17-036570Hepatitis EFranceCPD1.004.00$250.0052 YMU/A<-70C21-Sep-16Altona HEV RT-PCR Kit<100 copies/mLWANTAI HEV-IgM ElisaPositiveWANTAI HEV-IgG Elisa3.19 IU/mLPositive$250.00GenotypeU/AAdditional ResultsHCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative.
DLS17-036572Hepatitis EFranceCPD1.004.00$250.0047 YMU/A<-70C12-Mar-15Altona HEV RT-PCR Kit4,440 copies/mLWANTAI HEV-IgM ElisaNegativeWANTAI HEV-IgG ElisaNegative$250.00Genotype3Additional ResultsHCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative.
DLS17-036573Hepatitis EFranceCPD1.004.00$250.0044 YMU/A<-70C03-Nov-15Altona HEV RT-PCR Kit243,000 copies/mLWANTAI HEV-IgM ElisaPositiveWANTAI HEV-IgG Elisa0.90 IU/mLPositive$250.00Genotype3fAdditional ResultsHCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative.
DLS17-036574Hepatitis EFranceCPD1.007.00$250.0041 YMU/A<-70C13-Nov-15Altona HEV RT-PCR Kit<100 copies/mLWANTAI HEV-IgM ElisaNegativeWANTAI HEV-IgG ElisaNegative$250.00GenotypeU/AAdditional ResultsHCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative.
DLS17-036575Hepatitis EFranceCPD1.004.00$250.0054 YMU/A<-70C01-Dec-16Altona HEV RT-PCR Kit<100 copies/mLWANTAI HEV-IgM ElisaPositiveWANTAI HEV-IgG Elisa54.33 IU/mLPositive$250.00GenotypeU/AAdditional ResultsHCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative.
DLS17-036577Hepatitis EFranceCPD1.0013.00$250.0038 YMU/A<-70C29-Mar-16Altona HEV RT-PCR Kit12,300 copies/mLWANTAI HEV-IgM ElisaPositiveWANTAI HEV-IgG Elisa0.79 IU/mLPositive$250.00Genotype3Additional ResultsHCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative.
DLS17-036578Hepatitis EFranceCPD1.0013.00$250.0031 YMU/A<-70C25-Apr-16Altona HEV RT-PCR Kit12,600 copies/mLWANTAI HEV-IgM ElisaPositiveWANTAI HEV-IgG Elisa0.74 IU/mLPositive$250.00Genotype3fAdditional ResultsHCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative.
DLS17-036579Hepatitis EFranceCPD1.008.00$250.0070 YMU/A<-70C02-Sep-15Altona HEV RT-PCR Kit7,500 copies/mLWANTAI HEV-IgM ElisaPositiveWANTAI HEV-IgG Elisa0.33 IU/mLPositive$250.00Genotype3cAdditional ResultsHCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative.
DLS17-036580Hepatitis EFranceCPD1.004.00$250.0027 YMU/A<-70C02-Oct-15Altona HEV RT-PCR Kit162 copies/mLWANTAI HEV-IgM ElisaPositiveWANTAI HEV-IgG Elisa0.90 IU/mLPositive$250.00GenotypeU/AAdditional ResultsHCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative.
DLS17-036581Hepatitis EFranceCPD1.004.00$250.0024 YFU/A<-70C17-Nov-15Altona HEV RT-PCR Kit<100 copies/mLWANTAI HEV-IgM ElisaNegativeWANTAI HEV-IgG ElisaNegative$250.00GenotypeU/AAdditional ResultsHCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative.
DLS17-036582Hepatitis EFranceCPD1.004.00$250.0054 YMU/A<-70C08-Dec-15Altona HEV RT-PCR Kit<100 copies/mLWANTAI HEV-IgM ElisaNegativeWANTAI HEV-IgG ElisaNegative$250.00GenotypeU/AAdditional ResultsHCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative.
DLS17-036583Hepatitis EFranceCPD1.006.00$250.0029 YMU/A<-70C29-Jan-16Altona HEV RT-PCR Kit2,430 copies/mLWANTAI HEV-IgM ElisaPositiveWANTAI HEV-IgG Elisa0.61 IU/mLPositive$250.00Genotype3fAdditional ResultsHCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative.
DLS17-036584Hepatitis EFranceCPD1.005.00$250.0053 YMU/A<-70C25-Mar-16Altona HEV RT-PCR Kit<100 copies/mLWANTAI HEV-IgM ElisaPositiveWANTAI HEV-IgG Elisa11.23 IU/mLPositive$250.00GenotypeU/AAdditional ResultsHCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative.
DLS17-036585Hepatitis EFranceCPD1.004.00$250.0064 YFU/A<-70C02-Feb-16Altona HEV RT-PCR Kit4,760 copies/mLWANTAI HEV-IgM ElisaPositiveWANTAI HEV-IgG Elisa5.14 IU/mLPositive$250.00GenotypeU/AAdditional ResultsHCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative.
DLS17-036586Hepatitis EFranceCPD1.004.00$250.0023 YMU/A<-70C01-Jul-15Altona HEV RT-PCR Kit224 copies/mLSero HEV-IgMU/ASero HEV IgGU/A$250.00Genotype3iAdditional ResultsHCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative.
DLS17-036587Hepatitis EFranceCPD1.004.00$250.0053 YMU/A<-70C20-Jul-15Altona HEV RT-PCR Kit554 copies/mLWANTAI HEV-IgM ElisaPositiveWANTAI HEV-IgG Elisa0.36 IU/mLPositive$250.00Genotype3fAdditional ResultsHCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative.
DLS17-036588Hepatitis EFranceCPD1.006.00$250.0024 YMU/A<-70C18-Aug-15Altona HEV RT-PCR Kit44,900 copies/mLWANTAI HEV-IgM ElisaU/AWANTAI HEV-IgG ElisaNegative$250.00Genotype3iAdditional ResultsHCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative.
DLS17-036589Hepatitis EFranceCPD1.004.00$250.0042 YMU/A<-70C18-Dec-15Altona HEV RT-PCR Kit<100 copies/mLWANTAI HEV-IgM ElisaNegativeWANTAI HEV-IgG ElisaNegative$250.00GenotypeU/AAdditional ResultsHCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative.
DLS17-036591Hepatitis EFranceCPD1.004.00$250.0042 YMU/A<-70C11-May-16Altona HEV RT-PCR Kit1,360 copies/mLWANTAI HEV-IgM ElisaNegativeWANTAI HEV-IgG ElisaNegative$250.00GenotypeU/AAdditional ResultsHCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative.
DLS17-036593Hepatitis EFranceCPD1.004.00$250.0030 YMU/A<-70C30-Mar-16Altona HEV RT-PCR Kit369 copies/mLWANTAI HEV-IgM ElisaPositiveWANTAI HEV-IgG Elisa1.27 IU/mLPositive$250.00GenotypeU/AAdditional ResultsHCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative.
DLS16-67574Hepatitis EVietnamSerum1.008.00$250.0055 YMAsian<-70C07-Jun-17HEV IgM | ELISAPositiveHEV IgM$250.003-Series HepB VaccineNoOther Testing Results| ALT: 1793 U/L | AST: 1680 U/L | ALP: 169 U/L | Bilirubin: 304 umol/L | Serum Creatinine: 79 umol/L2-Jun-17Current Signs and SymptomsFatigue; JaundiceCo-InfectionsNoneCurrent Anti-Viral TherapyNoneHepatitis SerologyHEV IgM +5-Jun-2017Acquired Infection CategoryU/A
DLS16-67533Hepatitis EVietnamSerum1.0010.00$250.0047 YMAsian<-70C09-Jun-17HEV IgM | ELISAPositiveHEV IgM$250.003-Series HepB VaccineNoOther Testing Results| ALT: 186 U/L | AST: 751 U/L | Bilirubin: 82.7 umol/L | Serum Creatinine: 92 umol/L8-Jun-17Current Signs and SymptomsFatigue; JaundiceCo-InfectionsNoneCurrent Anti-Viral TherapyNoneHepatitis SerologyHEV IgM +6-Jun-2017Acquired Infection CategoryU/A
DLS16-67489Hepatitis EVietnamSerum1.0010.00$250.0068 YFAsian<-70C06-Jul-17HEV IgM | ELISAPositiveHEV IgM$250.003-Series HepB VaccineNoOther Testing Results| ALT: 743 U/L | AST: 531 U/L | ALP: 136 U/L | Bilirubin: 258 umol/L | Serum Creatinine: 82 umol/L29-Jun-17Current Signs and SymptomsDecreased appetite; Abdominal pain; Fatigue; JaundiceCo-InfectionsNoneCurrent Anti-Viral TherapyNoneHepatitis SerologyHEV IgM +29-Jun-2017Acquired Infection CategoryU/A
DLS16-67560Hepatitis EVietnamSerum1.0010.00$250.0044 YMAsian<-70C06-Jul-17HEV IgM | ELISAPositiveHEV IgM$250.003-Series HepB VaccineNoOther Testing Results| ALT: 82 U/L | AST: 156 U/L | Bilirubin: 18 umol/L | Serum Creatinine: 49 umol/L4-Jul-17Current Signs and SymptomsDecreased appetite; Abdominal pain; Fatigue; JaundiceCo-InfectionsNoneCurrent Anti-Viral TherapyNoneHepatitis SerologyHEV IgM +30-Jun-2017Acquired Infection CategoryU/A
DLS16-67528Hepatitis EVietnamSerum1.0014.00$250.0029 YFAsian<-70C07-Jul-17HEV IgM | ELISAPositiveHEV IgM$250.003-Series HepB VaccineNoOther Testing Results| ALT: 210 U/L | AST: 233 U/L | Bilirubin: 87 umol/L | Serum Creatinine: 76 umol/L30-Jun-17Current Signs and SymptomsFatigue; JaundiceCo-InfectionsNoneCurrent Anti-Viral TherapyNoneHepatitis SerologyHEV IgM +6-Jul-2017Acquired Infection CategoryU/A
DLS16-67773Hepatitis EVietnamSerum1.0010.00$250.0051 YMAsian<-70C07-Jul-17HEV IgM | ELISAPositiveHEV IgM$250.003-Series HepB VaccineNoOther Testing Results| ALT: 1851 U/L | AST: 2196 U/L | Bilirubin: 60 umol/L | Serum Creatinine: 82 umol/L30-Jun-17Current Signs and SymptomsAbdominal pain; Fatigue; JaundiceCo-InfectionsNoneCurrent Anti-Viral TherapyNoneHepatitis SerologyHEV IgM +6-Jul-2017Acquired Infection CategoryU/A
DLS16-67713Hepatitis EVietnamSerum1.0012.00$250.0034 YMAsian<-70C18-Jul-17HEV IgM | ELISAPositiveHEV IgM$250.003-Series HepB VaccineNoOther Testing Results| ALT: 123 U/L | AST: 352 U/L | Bilirubin: 34 umol/L | Serum Creatinine: 84 umol/L14-Jul-17Current Signs and SymptomsFatigue; JaundiceCo-InfectionsNoneCurrent Anti-Viral TherapyNoneHepatitis SerologyHEV IgM +12-Jul-2017Acquired Infection CategoryU/A
DLS16-67795Hepatitis EVietnamSerum1.0014.00$250.0070 YMAsian<-70C14-Jul-17HEV IgM | ELISAPositiveHEV IgM$250.003-Series HepB VaccineNoOther Testing Results| ALT: 857 U/L | AST: 1133 U/L | Bilirubin: 101.9 umol/L | Serum Creatinine: 82 umol/L10-Jul-17Current Signs and SymptomsDecreased appetite; Fatigue; JaundiceCo-InfectionsNoneCurrent Anti-Viral TherapyNoneHepatitis SerologyHEV IgM +13-Jul-2017Acquired Infection CategoryU/A
DLS16-67518Hepatitis EVietnamSerum1.0012.00$250.0068 YFAsian<-70C21-Jul-17HEV IgM | ELISAPositiveHEV IgM$250.003-Series HepB VaccineNoOther Testing Results| ALT: 201 U/L | AST: 478 U/L | Bilirubin: 58.5 umol/L | Serum Creatinine: 78 umol/L21-Jul-17Current Signs and SymptomsFatigue; JaundiceCo-InfectionsNoneCurrent Anti-Viral TherapyNoneHepatitis SerologyHEV IgM +20-Jul-2017Acquired Infection CategoryU/A
DLS16-67548Hepatitis EVietnamSerum1.009.00$250.0063 YFAsian<-70C26-Jul-17HEV IgM | ELISAPositiveHEV IgM$250.003-Series HepB VaccineNoOther Testing Results| ALT: 203 U/L | AST: 365 U/L | ALP: 186 U/L | LDH: 236 U/L | Bilirubin: 8.3 umol/L | Serum Creatinine: 82 umol/L18-Jul-17Current Signs and SymptomsDecreased appetite; Abdominal pain; Fatigue Co-InfectionsNoneCurrent Anti-Viral TherapyNoneHepatitis SerologyHEV IgM +25-Jul-2017Acquired Infection CategoryU/A
DLS17-050040-K2Hepatitis EVietnamK2 EDTA Plasma1.009.00$250.0053 YFAsian<-70C27-Dec-17HEV IgM | ELISAPositiveHEV IgM$250.00Hepatitis SerologyHEV IgM +Acquired Infection CategoryU/A3-Series HepB VaccineNoOther Testing ResultsALT: 90 U/L | AST: 46 U/L | Bilirubin: 38.5 umol/L | Creatinine: 74 umol/L Hepatitis E26-Dec-17Current Signs and SymptomsDecreased appetite; Abdominal pain; Fatigue; JaundiceCo-InfectionsNoneCurrent Anti-Viral TherapyNone
DLS17-050040-SHepatitis EVietnamSerum1.009.00$250.0053 YFAsian<-70C27-Dec-17HEV IgM | ELISAPositiveHEV IgM$250.00Hepatitis SerologyHEV IgM +Acquired Infection CategoryU/A3-Series HepB VaccineNoOther Testing ResultsALT: 90 U/L | AST: 46 U/L | Bilirubin: 38.5 umol/L | Creatinine: 74 umol/L Hepatitis E26-Dec-17Current Signs and SymptomsDecreased appetite; Abdominal pain; Fatigue; JaundiceCo-InfectionsNoneCurrent Anti-Viral TherapyNone
DLS17-050047-K2Hepatitis EVietnamK2 EDTA Plasma1.006.00$250.0065 YFAsian<-70C21-Dec-17HEV IgM | ELISAPositiveHEV IgM$250.00Hepatitis SerologyHEV IgM +Acquired Infection CategoryU/A3-Series HepB VaccineNoOther Testing ResultsALT: 46 U/L | AST: 78 U/L | Bilirubin: 20.2 umol/L | Creatinine: 59 umol/L Hepatitis E15-Dec-17Current Signs and SymptomsDecreased appetite; Abdominal pain; Fatigue; JaundiceCo-InfectionsNoneCurrent Anti-Viral TherapyNone
DLS17-050047-SHepatitis EVietnamSerum1.005.00$250.0065 YFAsian<-70C21-Dec-17HEV IgM | ELISAPositiveHEV IgM$250.00Hepatitis SerologyHEV IgM +Acquired Infection CategoryU/A3-Series HepB VaccineNoOther Testing ResultsALT: 46 U/L | AST: 78 U/L | Bilirubin: 20.2 umol/L | Creatinine: 59 umol/L Hepatitis E15-Dec-17Current Signs and SymptomsDecreased appetite; Abdominal pain; Fatigue; JaundiceCo-InfectionsNoneCurrent Anti-Viral TherapyNone
DLS17-050057-K2Hepatitis EVietnamK2 EDTA Plasma1.008.00$250.0038 YFAsian<-70C12-Sep-18HEV IgM | ELISAPositiveHEV IgM$250.00Hepatitis SerologyHEV IgM +Acquired Infection CategoryU/A3-Series HepB VaccineNoOther Testing ResultsALT: 590 U/L | AST: 114 U/L | Bilirubin: 119 umol/L | Creatinine: 64 umol/L Hepatitis E6-Sep-18Current Signs and SymptomsDecreased appetite; Abdominal pain; Fatigue; JaundiceCo-InfectionsHBV treatment naiveCurrent Anti-Viral TherapyNone
DLS17-050057-SHepatitis EVietnamSerum1.005.00$250.0038 YFAsian<-70C12-Sep-18HEV IgM | ELISAPositiveHEV IgM$250.00Hepatitis SerologyHEV IgM +Acquired Infection CategoryU/A3-Series HepB VaccineNoOther Testing ResultsALT: 590 U/L | AST: 114 U/L | Bilirubin: 119 umol/L | Creatinine: 64 umol/L Hepatitis E6-Sep-18Current Signs and SymptomsDecreased appetite; Abdominal pain; Fatigue; JaundiceCo-InfectionsHBV treatment naiveCurrent Anti-Viral TherapyNone
DLS17-050066-K2Hepatitis EVietnamK2 EDTA Plasma1.009.00$250.0069 YFAsian<-70C21-Aug-18HEV IgM | ELISAPositiveHEV IgM$250.00Hepatitis SerologyHEV IgM +Acquired Infection CategoryU/A3-Series HepB VaccineNoOther Testing ResultsALT: 508 U/L | AST: 174 U/L | Bilirubin: 251 umol/L | Creatinine: 51 umol/L Hepatitis E17-Aug-18Current Signs and SymptomsDecreased appetite; FatigueCo-InfectionsHBV since 2015, treatment naiveCurrent Anti-Viral TherapyNone
DLS17-050066-SHepatitis EVietnamSerum1.007.00$250.0069 YFAsian<-70C21-Aug-18HEV IgM | ELISAPositiveHEV IgM$250.00Hepatitis SerologyHEV IgM +Acquired Infection CategoryU/A3-Series HepB VaccineNoOther Testing ResultsALT: 508 U/L | AST: 174 U/L | Bilirubin: 251 umol/L | Creatinine: 51 umol/L Hepatitis E17-Aug-18Current Signs and SymptomsDecreased appetite; FatigueCo-InfectionsHBV since 2015, treatment naiveCurrent Anti-Viral TherapyNone
DLS17-050069-K2Hepatitis EVietnamK2 EDTA Plasma1.009.00$250.0060 YMAsian<-70C28-May-18HEV IgM | ELISAPositiveHEV IgM$250.00Hepatitis SerologyHEV IgM +Acquired Infection CategoryU/A3-Series HepB VaccineNoOther Testing ResultsALT: 482 U/L | AST: 387 U/L | Bilirubin: 558 umol/L | Creatinine: 110 umol/L Hepatitis E21-May-18Current Signs and SymptomsFatigue; JaundiceCo-InfectionsNoneCurrent Anti-Viral TherapyNone
DLS17-050069-SHepatitis EVietnamSerum1.009.00$250.0060 YMAsian<-70C28-May-18HEV IgM | ELISAPositiveHEV IgM$250.00Hepatitis SerologyHEV IgM +Acquired Infection CategoryU/A3-Series HepB VaccineNoOther Testing ResultsALT: 482 U/L | AST: 387 U/L | Bilirubin: 558 umol/L | Creatinine: 110 umol/L Hepatitis E21-May-18Current Signs and SymptomsFatigue; JaundiceCo-InfectionsNoneCurrent Anti-Viral TherapyNone
DLS17-050086-K2Hepatitis EVietnamK2 EDTA Plasma1.008.00$250.0034 YMAsian<-70C25-May-18HEV IgM | ELISAPositiveHEV IgM$250.00Hepatitis SerologyHEV IgM +Acquired Infection CategoryU/A3-Series HepB VaccineNoOther Testing ResultsALT: 212 U/L | AST: 148 U/L | Bilirubin: 137 umol/L | Creatinine: 82 umol/L Hepatitis E21-May-18Current Signs and SymptomsFatigue; JaundiceCo-InfectionsNoneCurrent Anti-Viral TherapyNone
DLS17-050086-SHepatitis EVietnamSerum1.007.00$250.0034 YMAsian<-70C25-May-18HEV IgM | ELISAPositiveHEV IgM$250.00Hepatitis SerologyHEV IgM +Acquired Infection CategoryU/A3-Series HepB VaccineNoOther Testing ResultsALT: 212 U/L | AST: 148 U/L | Bilirubin: 137 umol/L | Creatinine: 82 umol/L Hepatitis E21-May-18Current Signs and SymptomsFatigue; JaundiceCo-InfectionsNoneCurrent Anti-Viral TherapyNone
DLS17-050088-K2Hepatitis EVietnamK2 EDTA Plasma1.005.00$250.0040 YMAsian<-70C07-Sep-18HEV IgM | ELISAPositiveHEV IgM$250.00Hepatitis SerologyHEV IgM +Acquired Infection CategoryU/A3-Series HepB VaccineNoOther Testing ResultsALT: 281 U/L | AST: 233 U/L | Bilirubin: 176 umol/L | Creatinine: 75 umol/L Hepatitis E30-Sep-18Current Signs and SymptomsDecreased appetite; FatigueCo-InfectionsNoneCurrent Anti-Viral TherapyNone
DLS17-050088-SHepatitis EVietnamSerum1.003.00$250.0040 YMAsian<-70C07-Sep-18HEV IgM | ELISAPositiveHEV IgM$250.00Hepatitis SerologyHEV IgM +Acquired Infection CategoryU/A3-Series HepB VaccineNoOther Testing ResultsALT: 281 U/L | AST: 233 U/L | Bilirubin: 176 umol/L | Creatinine: 75 umol/L Hepatitis E30-Sep-18Current Signs and SymptomsDecreased appetite; FatigueCo-InfectionsNoneCurrent Anti-Viral TherapyNone
DLS17-050092-K2Hepatitis EVietnamK2 EDTA Plasma1.009.00$250.0069 YMAsian<-70C28-May-18HEV IgM | ELISAPositiveHEV IgM$250.00Hepatitis SerologyHEV IgM +Acquired Infection CategoryU/A3-Series HepB VaccineNoOther Testing ResultsALT: 280 U/L | AST: 100 U/L | Bilirubin: 299 umol/L | Creatinine: 77 umol/L Hepatitis E16-May-18Current Signs and SymptomsJaundiceCo-InfectionsNoneCurrent Anti-Viral TherapyNone
DLS17-050092-SHepatitis EVietnamSerum1.009.00$250.0069 YMAsian<-70C28-May-18HEV IgM | ELISAPositiveHEV IgM$250.00Hepatitis SerologyHEV IgM +Acquired Infection CategoryU/A3-Series HepB VaccineNoOther Testing ResultsALT: 280 U/L | AST: 100 U/L | Bilirubin: 299 umol/L | Creatinine: 77 umol/L Hepatitis E16-May-18Current Signs and SymptomsJaundiceCo-InfectionsNoneCurrent Anti-Viral TherapyNone
DLS17-050128-K2Hepatitis EVietnamK2 EDTA Plasma1.009.00$250.0036 YFAsian<-70C14-Mar-18HEV IgM | ELISAPositiveHEV IgM$250.00Hepatitis SerologyHEV IgM +Acquired Infection CategoryU/A3-Series HepB VaccineYesOther Testing ResultsALT: 109 U/L | AST: 218 U/L | Bilirubin: 179 umol/L | Creatinine: 62 umol/L Hepatitis E8-Mar-18Current Signs and SymptomsFatigue; JaundiceCo-InfectionsNoneCurrent Anti-Viral TherapyNone
DLS17-050128-SHepatitis EVietnamSerum1.007.00$250.0036 YFAsian<-70C14-Mar-18HEV IgM | ELISAPositiveHEV IgM$250.00Hepatitis SerologyHEV IgM +Acquired Infection CategoryU/A3-Series HepB VaccineYesOther Testing ResultsALT: 109 U/L | AST: 218 U/L | Bilirubin: 179 umol/L | Creatinine: 62 umol/L Hepatitis E8-Mar-18Current Signs and SymptomsFatigue; JaundiceCo-InfectionsNoneCurrent Anti-Viral TherapyNone
DLS17-050137-K2Hepatitis EVietnamK2 EDTA Plasma1.256.00$250.0039 YMAsian<-70C17-Apr-18HEV IgM | ELISAPositiveHEV IgM$250.00Hepatitis SerologyHEV IgM +Acquired Infection CategoryU/A3-Series HepB VaccineNoOther Testing ResultsALT: 108 U/L | AST: 179 U/L | Bilirubin: 273 umol/L | Creatinine: 89 umol/L Hepatitis E30-Mar-18Current Signs and SymptomsAbdominal pain; Fatigue; JaundiceCo-InfectionsNoneCurrent Anti-Viral TherapyNone
DLS17-050137-SHepatitis EVietnamSerum1.007.00$250.0039 YMAsian<-70C17-Apr-18HEV IgM | ELISAPositiveHEV IgM$250.00Hepatitis SerologyHEV IgM +Acquired Infection CategoryU/A3-Series HepB VaccineNoOther Testing ResultsALT: 108 U/L | AST: 179 U/L | Bilirubin: 273 umol/L | Creatinine: 89 umol/L Hepatitis E30-Mar-18Current Signs and SymptomsAbdominal pain; Fatigue; JaundiceCo-InfectionsNoneCurrent Anti-Viral TherapyNone
DLS17-050142-K2Hepatitis EVietnamK2 EDTA Plasma1.007.00$250.0047 YFAsian<-70C03-Aug-18HEV IgM | ELISAPositiveHEV IgM$250.00Hepatitis SerologyHEV IgM +Acquired Infection CategoryU/A3-Series HepB VaccineNoOther Testing ResultsALT: 894 U/L | AST: 108 U/L | Bilirubin: 17.1 umol/L | Creatinine: 43 umol/L Hepatitis E1-Aug-18Current Signs and SymptomsDecreased appetite; FatigueCo-InfectionsNoneCurrent Anti-Viral TherapyNone
DLS17-050142-SHepatitis EVietnamSerum1.004.00$250.0047 YFAsian<-70C03-Aug-18HEV IgM | ELISAPositiveHEV IgM$250.00Hepatitis SerologyHEV IgM +Acquired Infection CategoryU/A3-Series HepB VaccineNoOther Testing ResultsALT: 894 U/L | AST: 108 U/L | Bilirubin: 17.1 umol/L | Creatinine: 43 umol/L Hepatitis E1-Aug-18Current Signs and SymptomsDecreased appetite; FatigueCo-InfectionsNoneCurrent Anti-Viral TherapyNone
DLS17-050160-K2Hepatitis EVietnamK2 EDTA Plasma1.008.00$250.0041 YMAsian<-70C06-Aug-18HEV IgM | ELISAPositiveHEV IgM$250.00Hepatitis SerologyHEV IgM +Acquired Infection CategoryU/A3-Series HepB VaccineNoOther Testing ResultsALT: 182 U/L | AST: 541 U/L | Bilirubin: 404 umol/L | Creatinine: 102 umol/L Hepatitis E2-Aug-18Current Signs and SymptomsDecreased appetite; FatigueCo-InfectionsNoneCurrent Anti-Viral TherapyNone
DLS17-050160-SHepatitis EVietnamSerum1.006.00$250.0041 YMAsian<-70C06-Aug-18HEV IgM | ELISAPositiveHEV IgM$250.00Hepatitis SerologyHEV IgM +Acquired Infection CategoryU/A3-Series HepB VaccineNoOther Testing ResultsALT: 182 U/L | AST: 541 U/L | Bilirubin: 404 umol/L | Creatinine: 102 umol/L Hepatitis E2-Aug-18Current Signs and SymptomsDecreased appetite; FatigueCo-InfectionsNoneCurrent Anti-Viral TherapyNone
DLS17-050179-K2Hepatitis EVietnamK2 EDTA Plasma1.257.00$250.0052 YMAsian<-70C17-Apr-18HEV IgM | ELISAPositiveHEV IgM$250.00Hepatitis SerologyHEV IgM + ; HBsAg +Acquired Infection CategoryU/A3-Series HepB VaccineNoOther Testing ResultsALT: 289 U/L | AST: 114 U/L | Bilirubin: 475 umol/L | Creatinine: 148 umol/L Hepatitis E and Hepatitis B7-Apr-18Current Signs and SymptomsDecreased appetite; Abdominal pain; Fatigue; JaundiceCo-InfectionsHBV treatment naiveCurrent Anti-Viral TherapyNone
DLS17-050179-SHepatitis EVietnamSerum1.006.00$250.0052 YMAsian<-70C17-Apr-18HEV IgM | ELISAPositiveHEV IgM$250.00Hepatitis SerologyHEV IgM + ; HBsAg +Acquired Infection CategoryU/A3-Series HepB VaccineNoOther Testing ResultsALT: 289 U/L | AST: 114 U/L | Bilirubin: 475 umol/L | Creatinine: 148 umol/L Hepatitis E and Hepatitis B7-Apr-18Current Signs and SymptomsDecreased appetite; Abdominal pain; Fatigue; JaundiceCo-InfectionsHBV treatment naiveCurrent Anti-Viral TherapyNone

Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.

Please read carefully before purchasing:

Clinical specimens for research use only.

Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.

If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341

These products are supplied without warranty for suitability for specific applications or analytical determinations.

Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.